Physician profile
Alexander A Chang
NPI 1225356231
$2,228.47
in general payments reported to CMS, 2019-2025
20 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $854 · 2021: $214 · 2022: $30.35 · 2023: $19.04 · 2024: $353 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $352.14 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $313.93 | 2019-2021 | |
| Amarin Pharma, INC. | $226.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $218.88 | 2019-2025 | Airsupra, Breztri |
| Pfizer INC. | $200.17 | 2019-2024 | |
| Gilead Sciences, INC. | $184.92 | 2019-2020 | |
| Spr Therapeutics, INC | $153.68 | 2021 | |
| Glaxosmithkline, LLC. | $84.29 | 2020-2023 | Arexvy, Shingrix |
| Novo Nordisk INC | $81.08 | 2020-2024 | Ozempic, Rybelsus |
| Amgen INC. | $67.31 | 2020 | |
| Abbvie INC. | $59.56 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $53.39 | 2019-2024 | Gardasil 9, Gardasil, M-M-R II |
| Bardy Diagnostics, INC. | $51.42 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.01 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $31.26 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.35 | 2022 | |
| Edwards Lifesciences Corporation | $27.83 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Allergan, INC. | $24.41 | 2019 | |
| Sanofi Pasteur INC. | $14.53 | 2019 | |
| Artivion, INC. | $14.50 | 2024 | Photofix Decellularized Bovine Pericardium, Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.